Popular weight-loss drug doesn’t increase suicide risk, EU regulator says

A committee of the European Medicines Agency said Friday that a popular weight-loss drug doesn’t increase the risk of suicide.

Previous post Stocks look vulnerable now — and not because of inflation, the Fed or the election
Next post Musk has two weeks to turn the ship around, says Tesla bull who is losing faith